Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance
- PMID: 839445
Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance
Abstract
Under first-order conditions the activity of the hepatic drug-metabolizing enzymes may be closely approximated by the ratio of the in vitro kinetic constants Vmax and Km, which in turn is equivalent to the intrinsic clearance of the drug. In theory, after appropriate consideration for liver weight, blood flow and rug binding in the blood, the intrinsic clearance may be used to predict the extraction ratio for the total organ. This hypothesis was tested by comparing the predicted ratio based on a perfusion-limited model of hepatic elimination with that determined directly in the isolated perfused rat liver. Good agreement was obtained between the predicted and observed hepatic extraction ratios for antipyrine, carbamazepine, hexobarbital, phenytoin, propranolol, alprenolol and lidocaine, which span the extraction ratio from less than 0.1 to greater than 0.9.
Similar articles
-
A new model-independent physiological approach to study hepatic drug clearance and its applications.Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6389376 Review.
-
Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.Hepatology. 1993 Feb;17(2):301-6. Hepatology. 1993. PMID: 8428728
-
Effects of route of administration and blood flow on hepatic drug elimination.J Pharmacol Exp Ther. 1975 Dec;195(3):424-32. J Pharmacol Exp Ther. 1975. PMID: 1195129
-
Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.Drug Metab Dispos. 1977 Mar-Apr;5(2):179-84. Drug Metab Dispos. 1977. PMID: 15811
-
Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.Acta Physiol Scand Suppl. 1995;627:1-42. Acta Physiol Scand Suppl. 1995. PMID: 8848946 Review.
Cited by
-
Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.J Pharmacokinet Biopharm. 1989 Dec;17(6):687-719. doi: 10.1007/BF01062125. J Pharmacokinet Biopharm. 1989. PMID: 2635740
-
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.Antimicrob Agents Chemother. 2002 Sep;46(9):2752-64. doi: 10.1128/AAC.46.9.2752-2764.2002. Antimicrob Agents Chemother. 2002. PMID: 12183225 Free PMC article.
-
Lipophilic Metabolic Efficiency (LipMetE) and Drug Efficiency Indices to Explore the Metabolic Properties of the Substrates of Selected Cytochrome P450 Isoforms.ACS Omega. 2019 Dec 30;5(1):179-188. doi: 10.1021/acsomega.9b02344. eCollection 2020 Jan 14. ACS Omega. 2019. PMID: 31956764 Free PMC article.
-
A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.Br J Clin Pharmacol. 1980 Nov;10(5):491-7. doi: 10.1111/j.1365-2125.1980.tb01794.x. Br J Clin Pharmacol. 1980. PMID: 7437261 Free PMC article. Clinical Trial.
-
The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios.Pharm Res. 2002 Nov;19(11):1606-10. doi: 10.1023/a:1020765025857. Pharm Res. 2002. PMID: 12458665